Longer-term data fail to clear concern over Takeda's dengue vaccine

An additional six months of data from a late-stage trial of Takeda Pharmaceutical Co's experimental dengue vaccine again showed it failed to protect against one of the four types of the virus in an important patient group, researchers said on Saturday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news